New drug shows promise for fatty liver in early trial
NCT ID NCT00666016
First seen Dec 26, 2025 · Last updated May 12, 2026 · Updated 17 times
Summary
This study tested a drug called TRO19622 in 22 adults with non-alcoholic steatohepatitis (NASH), a type of fatty liver disease. Participants took either the drug or a placebo for one month to see if it safely lowered liver enzymes. The goal was to check short-term safety and effects on the liver.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU AMIENS, Service d'Hépato-Gastroentérologie
Amiens, 80054, France
-
Centre Hospitalier de Hyères, Hôpital de Jour, Service d'Hépato-Gastro-Entérologie
Hyères, 83407, France
-
Groupe Hospitalier Pitié-Salpétrière - Sce Hépato-Gastroentérologie - 47-83 Bd de l'Hôpital
Paris, 75651, France
-
Hôpital Archet 2 - Pôle de Référence Hépatite C (Niveau -2) - 151, route Saint Antoine de Ginestière
Nice, 06200, France
-
Hôpital Saint Joseph, Service d'Hépato-Gastro-Entérologie
Marseille, 13285, France
Conditions
Explore the condition pages connected to this study.